Regulation of m2 muscarinic receptor gene expression by platelet- derived growth factor: Involvement of extracellular signal-regulated protein kinases in the down-regulation process

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 966-973

  Rousell, Jonathan ^a   Haddad, El Bdaoui ^a   Lindsay, Mark A ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4BETA PHORBOL DIBUTYRATE; CARBACHOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC M2 RECEPTOR; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PLATELET DERIVED GROWTH FACTOR;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0031466319     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.966     Document Type: Article

References (35)

1. El-Fakahany, E. E., and C. L. Cioffi. Molecular mechanisms of regulation of neuronal muscarinic receptor sensitivity. Membr. Biochem. 9:9-27 (1990).
2. Moletauex J. M., and E. Hermans. Agonist-induced muscarinic cholinergic receptor internalization, recycling and degradation in cultured neuronal cells. Biochem. Pharmacol. 47:77-88 (1994).
3. Hosey, M. M., J. L. Benovic, S. K. DebBurman, and R. M. Richardson. Multiple mechanisms including protein phosphorylation are linked to desensitization of muscarinic receptors. Life Sci. 56:951-955 (1995).
4. Haga T., K. Haga K. Kameyama, and H. Nakata. Phosphorylation of muscarinic receptors: regulation by G proteins. Life Sci. 52:421-428 (1993).
5. Hill, S. J., and D. A. Kendall. Studies on the adenosine-receptor mediating the augmentation of histamine-induced inositol phospholipid hydrolysis in guinea-pig cerebral cortex. Br. J. Pharmacol. 91:661-669 (1987).
6. Schlessinger, J. SH2/SH3 signalling proteins. Curr. Opin. Genet. Dev. 4:25-30 (1994).
7. Marshall, C. J. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185 (1995).
8. Malarkey K., C. M. Belham, A. Paul, A. Graham, A. McLees, P. H. Scott, and R. Plevin. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem. J. 309:361-375 (1995).
9. Cano, E., and L. C. Mahadevan. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:117-120 (1995).
10. Pulverer, B. J., J. M. Kyriakas, J. Avruch, E. Nikolakaki, and J. R. Woodgett. Phosphorylation of c-jun by MAP kinases. Nature (Lond.) 353: 670-674 (1991).
11. Marias, R., J. Wynne, and R. Treisman. The SRF accessory protein Elk-1 contains a growth facto-regulated transcriptional activation domain. Cell 73:381-393 (1993).
12. Granot, Y., E. Erikson, H. Fridman, R. Van Putten, B. Williams, R. W. Schrier, and J. L. Maller. Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells. J. Biol. Chem 268:9564-9569 (1993).
13. Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marmé, and U. R. Rapp. Protein kinase C α activates RAF-1 by direct phosphorylation. Nature (Lond.) 364:249-252 (1993).
14. Gardener, A. M., R. R. Vaillancourt, and G. L. Johnson. Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins. J. Biol. Chem 269: 7851-7854 (1993).
15. Rousell, J., E.-B. Haddad, J. C. W. Mak, and P. J. Barnes. Transcriptional down-regulation of m2 muscarinic receptor gene expression in human embryonic lung (HEL 299) cells by protein kinase C. J. Biol. Chem. 270:7213-7218 (1995).
16. Haddad, E-B., J. Rousell, J. C. W. Mak, and P. J. Barnes. Transforming growth factor-β1 induces transcriptional down-regulation of m2 muscarinic receptor gene expression. Mol. Pharmacol. 49:781-787 (1996).
17. 2 receptor gene expression. J. Biol. Chem. 271:32586-32592 (1996).
18. Lowry, O. H, N. J. Roseborough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
19. Munson, P. J., and D. Rodbard. Ligand: a versatile computerized approach to characterization of ligand binding systems. Anal. Biochem. 107:220-239 (1980).
20. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by guanidinium thiocyanate-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
21. Brooker, G., J. F. Harper, W. L. Terasaki, and R. D. Moyolin. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10:1-33 (1979).
22. Greenberg, M. E., and E. B. Ziff. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (Lond.) 311:433-438 (1984).
23. Kameshita, I., and H. Fujisawa. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulphate-polyacrylamide gel. Anal. Biochem. 183:139-143 (1989).
24. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686-7689 (1995).
25. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494 (1995).
26. 2 muscarinic receptors: role of cAMP-dependent protein kinase and protein kinase C. Mol. Pharmacol. 49:629-635 (1996).
27. 2-niuscarinic receptors but not m2 receptor mRNA in a human lung cell line. Br. J. Pharmacol. 116:2027-2032 (1995).
28. Kapeller, R., and L. C. Cantley. Phosphatidylinositol 3-kinase. Bioessays. 16:565-576 (1994).
29. Akimoto, K., R. Takahashi, S. Moriya, N. Nishioka, J. Takayanagi, K. Kimura, Y. Fukui, S.-I. Osada, K. Mizuno, S.-I. Hirai, A. Kazlauskas, and S. Ohno. EGF or PDGF receptors activate atypical PKCλ through phosphoinositol 3-kinase. EMBO J. 15:788-798 (1996).
30. Arcaro, A., and M. P. Wymann. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296:297-301 (1993).
31. Toullec, D., P. Piantetti, H. Coste, P. Bellevergue, T. Grand-perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. The bisindolymaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781 (1991).
32. Graves, L. M., K. R. Bornfeld, J. S. Sidhu, G. M. Argast, E. W. Raines, R. Ross, C. C. Leslie, and E. G. Krebs. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J. Biol. Chem. 271:505-511 (1996).
33. Cobb, M. H., and E. J. Goldsmith. How MAP kinases are regulated. J. Biol. Chem. 270:14843-14846 (1995).
34. Crespo, P., N. Xu, W. F. Simonds, and J. S. Gutkind. Ras-dependent activation of MAP kinase pathway mediated by G protein βγ subunits. Nature (Lond.) 369:418-420 (1994).
35. Morrison, D. K., G. Heidecker, U. R. Rapp, and T. D. Copeland. Identification of the major phosphorylation sites of Raf-1 kinase. J. Biol. Chem. 268:17309-17316 (1993).